The Pragmatic Turn in Clinical Research
Bibliographic Data
| ID | 21237456 |
|---|---|
| Authors | Olga Zvonareva (0000-0001-5548-7491, National Research Tomsk State University, corresponding author) |
| Year | 2021 |
| Volume | 34 |
| Issue | 2 |
| Pages | 6-24 |
| Publication date | 2021-05-15 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Science & Technology Studies (JOURNAL) |
| Journal identifiers | ISSN: 2243-4690 • E-ISSN: 2243-4690 |
| Publisher | Science and Technology Studies (PUBLISHER) |
| DOI | 10.23987/sts.92043 |
| OpenAlex | W3161379139 |
| Language | EN |
| References cited | 21 |
How does knowledge obtained in clinical trials apply to the actual treatment of patients? This question has recently acquired a new significance amidst complaints about the limited ability of trial results to improve clinical practice. Pragmatic clinical trials have been advocated to address this problem. In this article, I trace the emergence of the pragmatic turn in clinical research, starting from the first mention of ‘pragmatic trial’ in 1967, and analyse the changes to how pragmatism has been conceived. I argue that contemporary version of pragmatism risks missing the mark by focusing exclusively on establishing similarity between the trial and the clinic for the purpose of greater generalizability. This focus eclipses the move for carefully aligning medical experimentation with conditions, needs and concerns in the clinic aimed at greater usefulness
Clinical Practice · Clinical trial · Developmental psychology · Engineering ethics · Epistemology · Family medicine · Generalizability theory · Pathology · Pragmatism · Computer Science · Ethics in Clinical Research · Health Systems, Economic Evaluations, Quality of Life · Medicine · Meta-analysis and systematic reviews · Philosophy · Psychology · Artificial Intelligence
Improving the reporting of pragmatic trials
Science's new social contract with society
Practical Clinical Trials
The PRECIS-2 tool
Efficacy and effectiveness trials (and other phases of research) in the development of health promotion programs
The Alchemy of Clinical Trials
Are RCTs the Gold Standard
(Re)configuring research value
A careful biomedicine? Generalization and abstraction in RCTs
Designs on Nature
Extending the rails
Why Don’t We See More Translation of Health Promotion Research to Practice? Rethinking the Efficacy-to-Effectiveness Transition
Antibiotics and the Social History of the Controlled Clinical Trial, 1950-1970
Laboratizing and de-laboratizing the world
Acting in an uncertain world
Blinding Authority
Trust and Mistrust in the Marketplace
Evidence-Based Medicine and the Implementation Gap
Resisting Evidence
Impure Science
| Highly cited | No |
|---|